Metal-Based Antibiotics and Therapeutics
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Novel Antimicrobial Agents".
Deadline for manuscript submissions: 31 October 2026 | Viewed by 1054
Special Issue Editors
Interests: biological inorganic chemistry; metallodrugs (anticancer/antimicrobial); metal–drug conjugates & SAR; DNA–enzyme–mitochondria interactions; mechanism of action & apoptosis; antimicrobial biomaterials (hydrogels, micelles, contact lenses); drug delivery & encapsulation; antithyroid drug mechanisms
Special Issues, Collections and Topics in MDPI journals
Interests: bioinorganic chemistry; biological inorganic chemistry; medicinal chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The use of metals and their salts as antiseptics dates back to ancient times, with applications documented across various civilizations. Among these, silver nitrate was employed extensively for its antimicrobial properties and maintained clinical significance as a topical antiseptic and antibacterial agent until the Second World War. A prominent example of continued medical relevance is silver sulfadiazine, which is primarily used for the treatment of burn wounds. This compound is included in the World Health Organization’s List of Essential Medicines, reflecting its critical role in basic health care.
The efficacy of traditional antibiotics is increasingly compromised by antimicrobial resistance (AMR), a global phenomenon driven by the adaptive mechanisms of microorganisms. Bacteria and other pathogens acquire resistance through genetic mutations and horizontal gene transfer, leading to reduced drug susceptibility and treatment failure. AMR affects both community-acquired and hospital-acquired infections, placing considerable strain on healthcare systems. If current trends persist, it is projected that by 2050, deaths from infections due antibiotic-resistant diseases could surpass deaths from cancer, underscoring the urgent need for alternative therapeutic strategies.
In recent years, research efforts have focused on metal-based antibiotics, materials, nanoparticles, and related metallotherapeutics that act through mechanisms distinct from those of conventional agents. These compounds may interact with microbial membranes, proteins, or genetic material in ways that limit the development of resistance. Studies continue to investigate the biological activity, stability, and specificity of metal complexes, with the goal of expanding the current antimicrobial arsenal.
This Special Issue on "Metal-Based Antibiotics and Therapeutics" aims to provide an overview of this increasingly diversified topic, presenting current advancements and the most recent research with a focus on the function of compounds containing silver, gold, copper, zinc, and other metal ions as antibiotics. This Special Issue will provide readers with a more comprehensive understanding of antibacterial metal complexes.
Prof. Dr. Sotiris K Hadjikakou
Dr. Christina N. Banti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biological inorganic chemistry
- metallotherapeutics
- metal-based antibiotics
- antimicrobial compounds
- antimicrobial resistance (AMR)
- antimicrobials materials or nanoparticles
- active medical devices
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
